Industry Research Reports

Home > Reports > Service & Software > Spatial Proteomics and Transcriptomics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Spatial Proteomics and Transcriptomics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-17

Pages: 188 Pages

Report ld: 6977576

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Proteomics and Transcriptomics Services Market Size(US$)

CAGR 2026-2032

14.4%

Market Size,2032

USD 470

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 210 million

Market Forecast in 2032(Value)

US$ 470 million

CAGR

14.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Spatial Proteomics and Transcriptomics Services was estimated to be worth US$ 188 million in 2025 and is projected to reach US$ 470 million, growing at a CAGR of 14.4% from 2026 to 2032.

Spatial Proteomics and Transcriptomics Services refer to specialized research services that integrate spatial biology technologies to simultaneously characterize RNA expression patterns and protein expression profiles while preserving the original spatial architecture of tissues and cells. By combining spatial transcriptomic and spatial proteomic information with advanced bioinformatics analysis, these services enable multidimensional investigation of gene regulation, protein function, cellular interactions, and tissue microenvironment.

Unlike conventional transcriptomics or proteomics approaches that analyze molecular changes from bulk samples, spatial proteomics and transcriptomics services provide answers to critical biological questions including which genes and proteins are altered, which cells express these molecules, where they are located within tissues, and how different cellular populations interact within biological environments.

These services typically integrate spatial transcriptomics platforms, spatial protein detection technologies, single-cell analysis, high-resolution imaging systems, and artificial intelligence-based spatial data analytics. Major technology platforms include 10x Genomics Visium/Xenium, Vizgen MERSCOPE MERFISH, NanoString/Bruker GeoMx DSP, Akoya PhenoCycler-Fusion, and Standard BioTools Hyperion Imaging Mass Cytometry. They provide end-to-end solutions covering sample preparation, spatial profiling, computational analysis, and biological interpretation. (vizgen.com)

Spatial Proteomics and Transcriptomics Services are widely applied in oncology, immunotherapy, precision medicine, drug mechanism studies, disease classification, biomarker discovery, and pharmaceutical development.

Spatial Proteomics and Transcriptomics Services primarily operate under a technology-intensive CRO model combining advanced spatial omics platforms, specialized laboratory expertise, and bioinformatics capabilities. Service providers establish comprehensive spatial biology infrastructure, including tissue processing systems, spatial RNA profiling platforms, spatial protein detection technologies, high-resolution imaging systems, mass spectrometry platforms, and computational analysis pipelines.

Typical workflows include project design, sample quality assessment, tissue preparation, spatial probe or antibody labeling, spatial signal acquisition, sequencing or imaging analysis, cell-type identification, spatial clustering, multi-omics integration, and biological reporting.

The industry value chain includes upstream suppliers of spatial omics instruments, sequencing platforms, mass spectrometry systems, imaging technologies, spatial probes, antibodies, and bioinformatics software. The midstream sector consists of spatial multi-omics CRO providers, life science service companies, and research technology platforms. Downstream customers include pharmaceutical companies, biotechnology companies, academic institutions, hospitals, and precision medicine organizations.

Due to high instrument investment, specialized expertise, and complex computational requirements, spatial proteomics and transcriptomics services represent a high-value-added research segment. Standardized spatial transcriptomics services generally achieve gross margins of approximately 40%-60%. Advanced integrated spatial proteomics-transcriptomics projects, multi-omics analysis, and pharmaceutical discovery applications may achieve margins of 55%-75%. Companies with proprietary algorithms, databases, automated workflows, and pharmaceutical partnerships may achieve margins approaching 70%.

Spatial Proteomics and Transcriptomics Services are becoming a strategic growth area in life science research and innovative drug discovery. As precision medicine evolves from conventional molecular profiling toward spatially resolved, single-cell, and integrated biological analysis, demand for understanding tissue microenvironments, cellular heterogeneity, and molecular interactions continues to increase.

Spatial multi-omics provides both RNA expression information and protein functional information, creating significant value in immuno-oncology, targeted drug development, biomarker discovery, and patient stratification. Advances in AI-based image analysis, high-throughput spatial profiling platforms, and multi-omics databases will further enhance the commercial value of these services.

The spatial proteomics and transcriptomics service market faces challenges including high equipment investment, complex workflows, limited analytical standardization, and relatively long clinical translation cycles. The field requires integration of histology, molecular detection, imaging, sequencing, and artificial intelligence technologies, creating high capability barriers.

Data interoperability among platforms, standardized workflows, and large-scale commercialization remain important challenges. Companies need to continuously strengthen automation, computational capabilities, and proprietary data resources to establish sustainable competitive advantages.

Future demand for spatial proteomics and transcriptomics services will increasingly focus on pharmaceutical development, clinical translation, and multi-omics integration. Pharmaceutical companies will increasingly adopt spatial multi-omics technologies for mechanism-of-action studies, immune microenvironment analysis, companion diagnostics, and patient stratification.

Biotechnology companies will leverage specialized CRO services to reduce investment in expensive infrastructure and accelerate innovation pipelines. Research institutions and healthcare organizations will expand applications in oncology, neuroscience, developmental biology, and complex disease research.

As spatial biology becomes a fundamental infrastructure for modern life sciences, service providers with global delivery capabilities, advanced technology platforms, and powerful data analytics capabilities will capture significant market opportunities.

This report provides a comprehensive view of the global market for Spatial Proteomics and Transcriptomics Services, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Spatial Proteomics and Transcriptomics Services market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Spatial Proteomics and Transcriptomics Services.

MARKET SEGMENTATION

By Company

Standard Biotools
Bruker Spatial Biology
BostonGene
CellCarta
APTBIO
Vizgen
PTM BIO
Crown Bioscience
Biodesix
BGI Genomics
Shanghai OE Biotech
Westlake Omics
MRM Proteomics
Shanghai Bioprofile
Creative Proteomics
MtoZ-Biolabs
Lc-Bio Technologies
Labcorp
Precision Biomarker Laboratories (PBL)
Metware Biotechnology
Cosmos Wisdom
MS Bioworks
Quanterix
CD Genomics
Discovery Life Sciences
Syncell
Illumina
Psomagen
GENEWIZ (Azenta Life Sciences)
Novogene
Creative Bioarray
SeqMatic

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Spatial Proteomics Services
Spatial Transcriptomics Services

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Spatial Proteomics and Transcriptomics Services companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Spatial Proteomics and Transcriptomics Services revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Spatial Proteomics and Transcriptomics Services revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Spatial Proteomics and Transcriptomics Services Product Introduction

1.2 Global Spatial Proteomics and Transcriptomics Services Market Size Forecast (2021–2032)

1.3 Spatial Proteomics and Transcriptomics Services Market Trends & Drivers

1.3.1 Spatial Proteomics and Transcriptomics Services Industry Trends

1.3.2 Spatial Proteomics and Transcriptomics Services Market Drivers & Opportunities

1.3.3 Spatial Proteomics and Transcriptomics Services Market Challenges

1.3.4 Spatial Proteomics and Transcriptomics Services Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Spatial Proteomics and Transcriptomics Services Players Revenue Ranking (2025)

2.2 Global Spatial Proteomics and Transcriptomics Services Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Spatial Proteomics and Transcriptomics Services Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Spatial Proteomics and Transcriptomics Services

2.6 Spatial Proteomics and Transcriptomics Services Market Competitive Analysis

2.6.1 Spatial Proteomics and Transcriptomics Services Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Spatial Proteomics and Transcriptomics Services Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Proteomics and Transcriptomics Services revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Spatial Proteomics and Transcriptomics Services Market Classification

3.1 Introduction by Type

3.1.1 Spatial Proteomics Services

3.1.2 Spatial Transcriptomics Services

3.1.3 Global Spatial Proteomics and Transcriptomics Services Sales Value by Type

3.1.3.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Spatial Proteomics and Transcriptomics Services Sales Value, by Type (2021–2032)

3.1.3.3 Global Spatial Proteomics and Transcriptomics Services Sales Value, by Type (%), 2021–2032

3.2 Introduction by End User

3.2.1 Universities and Research Institutes

3.2.2 Hospitals

3.2.3 Pharmaceutical Companies

3.2.4 Others

3.2.5 Global Spatial Proteomics and Transcriptomics Services Sales Value by End User

3.2.5.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by End User (2021 vs 2025 vs 2032)

3.2.5.2 Global Spatial Proteomics and Transcriptomics Services Sales Value, by End User (2021–2032)

3.2.5.3 Global Spatial Proteomics and Transcriptomics Services Sales Value, by End User (%), 2021–2032

3.3 Introduction by Research Areas

3.3.1 Oncology

3.3.2 Cardiovascular

3.3.3 Agriculture

3.3.4 Neuroscience

3.3.5 Other

3.3.6 Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas

3.3.6.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas (2021 vs 2025 vs 2032)

3.3.6.2 Global Spatial Proteomics and Transcriptomics Services Sales Value, by Research Areas (2021–2032)

3.3.6.3 Global Spatial Proteomics and Transcriptomics Services Sales Value, by Research Areas (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinical Diagnostics

4.1.2 Drug Discovery

4.1.3 Others

4.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application

4.2.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021–2032)

4.2.3 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region

5.1.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2021–2026)

5.1.3 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2027–2032)

5.1.4 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

5.2.2 North America Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

5.3.2 Europe Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

5.4.2 Asia Pacific Spatial Proteomics and Transcriptomics Services Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

5.5.2 South America Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

5.6.2 Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.3 United States

6.3.1 United States Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.3.2 United States Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.4.2 Europe Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.5.2 China Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.5.3 China Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.6.2 Japan Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.7.2 South Korea Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.8.2 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Spatial Proteomics and Transcriptomics Services Sales Value, 2021–2032

6.9.2 India Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

6.9.3 India Spatial Proteomics and Transcriptomics Services Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Standard Biotools

7.1.1 Standard Biotools Profile

7.1.2 Standard Biotools Main Business

7.1.3 Standard Biotools Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.1.4 Standard Biotools Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.1.5 Standard Biotools Recent Developments

7.2 Bruker Spatial Biology

7.2.1 Bruker Spatial Biology Profile

7.2.2 Bruker Spatial Biology Main Business

7.2.3 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.2.4 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.2.5 Bruker Spatial Biology Recent Developments

7.3 BostonGene

7.3.1 BostonGene Profile

7.3.2 BostonGene Main Business

7.3.3 BostonGene Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.3.4 BostonGene Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.3.5 BostonGene Recent Developments

7.4 CellCarta

7.4.1 CellCarta Profile

7.4.2 CellCarta Main Business

7.4.3 CellCarta Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.4.4 CellCarta Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.4.5 CellCarta Recent Developments

7.5 APTBIO

7.5.1 APTBIO Profile

7.5.2 APTBIO Main Business

7.5.3 APTBIO Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.5.4 APTBIO Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.5.5 APTBIO Recent Developments

7.6 Vizgen

7.6.1 Vizgen Profile

7.6.2 Vizgen Main Business

7.6.3 Vizgen Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.6.4 Vizgen Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.6.5 Vizgen Recent Developments

7.7 PTM BIO

7.7.1 PTM BIO Profile

7.7.2 PTM BIO Main Business

7.7.3 PTM BIO Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.7.4 PTM BIO Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.7.5 PTM BIO Recent Developments

7.8 Crown Bioscience

7.8.1 Crown Bioscience Profile

7.8.2 Crown Bioscience Main Business

7.8.3 Crown Bioscience Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.8.4 Crown Bioscience Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.8.5 Crown Bioscience Recent Developments

7.9 Biodesix

7.9.1 Biodesix Profile

7.9.2 Biodesix Main Business

7.9.3 Biodesix Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.9.4 Biodesix Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.9.5 Biodesix Recent Developments

7.10 BGI Genomics

7.10.1 BGI Genomics Profile

7.10.2 BGI Genomics Main Business

7.10.3 BGI Genomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.10.4 BGI Genomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.10.5 BGI Genomics Recent Developments

7.11 Shanghai OE Biotech

7.11.1 Shanghai OE Biotech Profile

7.11.2 Shanghai OE Biotech Main Business

7.11.3 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.11.4 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.11.5 Shanghai OE Biotech Recent Developments

7.12 Westlake Omics

7.12.1 Westlake Omics Profile

7.12.2 Westlake Omics Main Business

7.12.3 Westlake Omics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.12.4 Westlake Omics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.12.5 Westlake Omics Recent Developments

7.13 MRM Proteomics

7.13.1 MRM Proteomics Profile

7.13.2 MRM Proteomics Main Business

7.13.3 MRM Proteomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.13.4 MRM Proteomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.13.5 MRM Proteomics Recent Developments

7.14 Shanghai Bioprofile

7.14.1 Shanghai Bioprofile Profile

7.14.2 Shanghai Bioprofile Main Business

7.14.3 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.14.4 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.14.5 Shanghai Bioprofile Recent Developments

7.15 Creative Proteomics

7.15.1 Creative Proteomics Profile

7.15.2 Creative Proteomics Main Business

7.15.3 Creative Proteomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.15.4 Creative Proteomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.15.5 Creative Proteomics Recent Developments

7.16 MtoZ-Biolabs

7.16.1 MtoZ-Biolabs Profile

7.16.2 MtoZ-Biolabs Main Business

7.16.3 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.16.4 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.16.5 MtoZ-Biolabs Recent Developments

7.17 Lc-Bio Technologies

7.17.1 Lc-Bio Technologies Profile

7.17.2 Lc-Bio Technologies Main Business

7.17.3 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.17.4 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.17.5 Lc-Bio Technologies Recent Developments

7.18 Labcorp

7.18.1 Labcorp Profile

7.18.2 Labcorp Main Business

7.18.3 Labcorp Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.18.4 Labcorp Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.18.5 Labcorp Recent Developments

7.19 Precision Biomarker Laboratories (PBL)

7.19.1 Precision Biomarker Laboratories (PBL) Profile

7.19.2 Precision Biomarker Laboratories (PBL) Main Business

7.19.3 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.19.4 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.19.5 Precision Biomarker Laboratories (PBL) Recent Developments

7.20 Metware Biotechnology

7.20.1 Metware Biotechnology Profile

7.20.2 Metware Biotechnology Main Business

7.20.3 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.20.4 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.20.5 Metware Biotechnology Recent Developments

7.21 Cosmos Wisdom

7.21.1 Cosmos Wisdom Profile

7.21.2 Cosmos Wisdom Main Business

7.21.3 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.21.4 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.21.5 Cosmos Wisdom Recent Developments

7.22 MS Bioworks

7.22.1 MS Bioworks Profile

7.22.2 MS Bioworks Main Business

7.22.3 MS Bioworks Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.22.4 MS Bioworks Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.22.5 MS Bioworks Recent Developments

7.23 Quanterix

7.23.1 Quanterix Profile

7.23.2 Quanterix Main Business

7.23.3 Quanterix Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.23.4 Quanterix Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.23.5 Quanterix Recent Developments

7.24 CD Genomics

7.24.1 CD Genomics Profile

7.24.2 CD Genomics Main Business

7.24.3 CD Genomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.24.4 CD Genomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.24.5 CD Genomics Recent Developments

7.25 Discovery Life Sciences

7.25.1 Discovery Life Sciences Profile

7.25.2 Discovery Life Sciences Main Business

7.25.3 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.25.4 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.25.5 Discovery Life Sciences Recent Developments

7.26 Syncell

7.26.1 Syncell Profile

7.26.2 Syncell Main Business

7.26.3 Syncell Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.26.4 Syncell Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.26.5 Syncell Recent Developments

7.27 Illumina

7.27.1 Illumina Profile

7.27.2 Illumina Main Business

7.27.3 Illumina Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.27.4 Illumina Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.27.5 Illumina Recent Developments

7.28 Psomagen

7.28.1 Psomagen Profile

7.28.2 Psomagen Main Business

7.28.3 Psomagen Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.28.4 Psomagen Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.28.5 Psomagen Recent Developments

7.29 GENEWIZ (Azenta Life Sciences)

7.29.1 GENEWIZ (Azenta Life Sciences) Profile

7.29.2 GENEWIZ (Azenta Life Sciences) Main Business

7.29.3 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.29.4 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.29.5 GENEWIZ (Azenta Life Sciences) Recent Developments

7.30 Novogene

7.30.1 Novogene Profile

7.30.2 Novogene Main Business

7.30.3 Novogene Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.30.4 Novogene Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.30.5 Novogene Recent Developments

7.31 Creative Bioarray

7.31.1 Creative Bioarray Profile

7.31.2 Creative Bioarray Main Business

7.31.3 Creative Bioarray Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.31.4 Creative Bioarray Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.31.5 Creative Bioarray Recent Developments

7.32 SeqMatic

7.32.1 SeqMatic Profile

7.32.2 SeqMatic Main Business

7.32.3 SeqMatic Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

7.32.4 SeqMatic Spatial Proteomics and Transcriptomics Services Revenue (US$ Million), 2021–2026

7.32.5 SeqMatic Recent Developments

8 Industry Chain Analysis

8.1 Spatial Proteomics and Transcriptomics Services Value Chain

8.2 Spatial Proteomics and Transcriptomics Services Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Spatial Proteomics and Transcriptomics Services Sales Model

8.5.2 Sales Channels

8.5.3 Spatial Proteomics and Transcriptomics Services Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Spatial Proteomics and Transcriptomics Services Market Trends

Table 2. Spatial Proteomics and Transcriptomics Services Market Drivers & Opportunities

Table 3. Spatial Proteomics and Transcriptomics Services Market Challenges

Table 4. Spatial Proteomics and Transcriptomics Services Market Restraints

Table 5. Global Spatial Proteomics and Transcriptomics Services Revenue by Company (US$ Million), 2021–2026

Table 6. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Spatial Proteomics and Transcriptomics Services Product Type

Table 9. Key Companies General Availability (GA) Timeline for Spatial Proteomics and Transcriptomics Services

Table 10. Global Spatial Proteomics and Transcriptomics Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Proteomics and Transcriptomics Services revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Type (2021–2026)

Table 17. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Type (2027–2032)

Table 18. Global Spatial Proteomics and Transcriptomics Services Sales Value by End User: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Spatial Proteomics and Transcriptomics Services Sales Value by End User (US$ Million), 2021–2026

Table 20. Global Spatial Proteomics and Transcriptomics Services Sales Value by End User (US$ Million), 2027–2032

Table 21. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by End User (2021–2026)

Table 22. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by End User (2027–2032)

Table 23. Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas (US$ Million), 2021–2026

Table 25. Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas (US$ Million), 2027–2032

Table 26. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Research Areas (2021–2026)

Table 27. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Research Areas (2027–2032)

Table 28. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Application (2021–2026)

Table 32. Global Spatial Proteomics and Transcriptomics Services Sales Market Share in Value by Application (2027–2032)

Table 33. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (%), 2021–2026

Table 37. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value, (US$ Million), 2027–2032

Table 41. Standard Biotools Basic Information List

Table 42. Standard Biotools Description and Business Overview

Table 43. Standard Biotools Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Standard Biotools (2021–2026)

Table 45. Standard Biotools Recent Developments

Table 46. Bruker Spatial Biology Basic Information List

Table 47. Bruker Spatial Biology Description and Business Overview

Table 48. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Bruker Spatial Biology (2021–2026)

Table 50. Bruker Spatial Biology Recent Developments

Table 51. BostonGene Basic Information List

Table 52. BostonGene Description and Business Overview

Table 53. BostonGene Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of BostonGene (2021–2026)

Table 55. BostonGene Recent Developments

Table 56. CellCarta Basic Information List

Table 57. CellCarta Description and Business Overview

Table 58. CellCarta Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of CellCarta (2021–2026)

Table 60. CellCarta Recent Developments

Table 61. APTBIO Basic Information List

Table 62. APTBIO Description and Business Overview

Table 63. APTBIO Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of APTBIO (2021–2026)

Table 65. APTBIO Recent Developments

Table 66. Vizgen Basic Information List

Table 67. Vizgen Description and Business Overview

Table 68. Vizgen Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Vizgen (2021–2026)

Table 70. Vizgen Recent Developments

Table 71. PTM BIO Basic Information List

Table 72. PTM BIO Description and Business Overview

Table 73. PTM BIO Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of PTM BIO (2021–2026)

Table 75. PTM BIO Recent Developments

Table 76. Crown Bioscience Basic Information List

Table 77. Crown Bioscience Description and Business Overview

Table 78. Crown Bioscience Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Crown Bioscience (2021–2026)

Table 80. Crown Bioscience Recent Developments

Table 81. Biodesix Basic Information List

Table 82. Biodesix Description and Business Overview

Table 83. Biodesix Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Biodesix (2021–2026)

Table 85. Biodesix Recent Developments

Table 86. BGI Genomics Basic Information List

Table 87. BGI Genomics Description and Business Overview

Table 88. BGI Genomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of BGI Genomics (2021–2026)

Table 90. BGI Genomics Recent Developments

Table 91. Shanghai OE Biotech Basic Information List

Table 92. Shanghai OE Biotech Description and Business Overview

Table 93. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Shanghai OE Biotech (2021–2026)

Table 95. Shanghai OE Biotech Recent Developments

Table 96. Westlake Omics Basic Information List

Table 97. Westlake Omics Description and Business Overview

Table 98. Westlake Omics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Westlake Omics (2021–2026)

Table 100. Westlake Omics Recent Developments

Table 101. MRM Proteomics Basic Information List

Table 102. MRM Proteomics Description and Business Overview

Table 103. MRM Proteomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of MRM Proteomics (2021–2026)

Table 105. MRM Proteomics Recent Developments

Table 106. Shanghai Bioprofile Basic Information List

Table 107. Shanghai Bioprofile Description and Business Overview

Table 108. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Shanghai Bioprofile (2021–2026)

Table 110. Shanghai Bioprofile Recent Developments

Table 111. Creative Proteomics Basic Information List

Table 112. Creative Proteomics Description and Business Overview

Table 113. Creative Proteomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Creative Proteomics (2021–2026)

Table 115. Creative Proteomics Recent Developments

Table 116. MtoZ-Biolabs Basic Information List

Table 117. MtoZ-Biolabs Description and Business Overview

Table 118. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of MtoZ-Biolabs (2021–2026)

Table 120. MtoZ-Biolabs Recent Developments

Table 121. Lc-Bio Technologies Basic Information List

Table 122. Lc-Bio Technologies Description and Business Overview

Table 123. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Lc-Bio Technologies (2021–2026)

Table 125. Lc-Bio Technologies Recent Developments

Table 126. Labcorp Basic Information List

Table 127. Labcorp Description and Business Overview

Table 128. Labcorp Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Labcorp (2021–2026)

Table 130. Labcorp Recent Developments

Table 131. Precision Biomarker Laboratories (PBL) Basic Information List

Table 132. Precision Biomarker Laboratories (PBL) Description and Business Overview

Table 133. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Precision Biomarker Laboratories (PBL) (2021–2026)

Table 135. Precision Biomarker Laboratories (PBL) Recent Developments

Table 136. Metware Biotechnology Basic Information List

Table 137. Metware Biotechnology Description and Business Overview

Table 138. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Metware Biotechnology (2021–2026)

Table 140. Metware Biotechnology Recent Developments

Table 141. Cosmos Wisdom Basic Information List

Table 142. Cosmos Wisdom Description and Business Overview

Table 143. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Cosmos Wisdom (2021–2026)

Table 145. Cosmos Wisdom Recent Developments

Table 146. MS Bioworks Basic Information List

Table 147. MS Bioworks Description and Business Overview

Table 148. MS Bioworks Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of MS Bioworks (2021–2026)

Table 150. MS Bioworks Recent Developments

Table 151. Quanterix Basic Information List

Table 152. Quanterix Description and Business Overview

Table 153. Quanterix Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 154. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Quanterix (2021–2026)

Table 155. Quanterix Recent Developments

Table 156. CD Genomics Basic Information List

Table 157. CD Genomics Description and Business Overview

Table 158. CD Genomics Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 159. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of CD Genomics (2021–2026)

Table 160. CD Genomics Recent Developments

Table 161. Discovery Life Sciences Basic Information List

Table 162. Discovery Life Sciences Description and Business Overview

Table 163. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 164. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Discovery Life Sciences (2021–2026)

Table 165. Discovery Life Sciences Recent Developments

Table 166. Syncell Basic Information List

Table 167. Syncell Description and Business Overview

Table 168. Syncell Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 169. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Syncell (2021–2026)

Table 170. Syncell Recent Developments

Table 171. Illumina Basic Information List

Table 172. Illumina Description and Business Overview

Table 173. Illumina Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 174. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Illumina (2021–2026)

Table 175. Illumina Recent Developments

Table 176. Psomagen Basic Information List

Table 177. Psomagen Description and Business Overview

Table 178. Psomagen Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 179. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Psomagen (2021–2026)

Table 180. Psomagen Recent Developments

Table 181. GENEWIZ (Azenta Life Sciences) Basic Information List

Table 182. GENEWIZ (Azenta Life Sciences) Description and Business Overview

Table 183. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 184. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of GENEWIZ (Azenta Life Sciences) (2021–2026)

Table 185. GENEWIZ (Azenta Life Sciences) Recent Developments

Table 186. Novogene Basic Information List

Table 187. Novogene Description and Business Overview

Table 188. Novogene Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 189. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Novogene (2021–2026)

Table 190. Novogene Recent Developments

Table 191. Creative Bioarray Basic Information List

Table 192. Creative Bioarray Description and Business Overview

Table 193. Creative Bioarray Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 194. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Creative Bioarray (2021–2026)

Table 195. Creative Bioarray Recent Developments

Table 196. SeqMatic Basic Information List

Table 197. SeqMatic Description and Business Overview

Table 198. SeqMatic Spatial Proteomics and Transcriptomics Services Products, Services, and Solutions

Table 199. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of SeqMatic (2021–2026)

Table 200. SeqMatic Recent Developments

Table 201. Revenue (US$ Million) in Spatial Proteomics and Transcriptomics Services Business of Company 40 (2021–2026)

Table 202. Company 40 Recent Developments

Table 203. Key Raw Materials Lists

Table 204. Key Suppliers of Raw Materials Lists

Table 205. Spatial Proteomics and Transcriptomics Services Downstream Customers

Table 206. Spatial Proteomics and Transcriptomics Services Distributors List

Table 207. Research Programs/Design for This Report

Table 208. Key Data Information from Secondary Sources

Table 209. Key Data Information from Primary Sources

List of Figures

Figure 1. Spatial Proteomics and Transcriptomics Services Product Picture

Figure 2. Global Spatial Proteomics and Transcriptomics Services Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 4. Spatial Proteomics and Transcriptomics Services Report Years Considered

Figure 5. Global Spatial Proteomics and Transcriptomics Services Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Spatial Proteomics and Transcriptomics Services Revenue in 2025

Figure 7. Spatial Proteomics and Transcriptomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Spatial Proteomics Services Picture

Figure 9. Spatial Transcriptomics Services Picture

Figure 10. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by Type, 2025 & 2032

Figure 12. Universities and Research Institutes Picture

Figure 13. Hospitals Picture

Figure 14. Pharmaceutical Companies Picture

Figure 15. Others Picture

Figure 16. Global Spatial Proteomics and Transcriptomics Services Sales Value by End User (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by End User, 2025 & 2032

Figure 18. Oncology Picture

Figure 19. Cardiovascular Picture

Figure 20. Agriculture Picture

Figure 21. Neuroscience Picture

Figure 22. Other Picture

Figure 23. Global Spatial Proteomics and Transcriptomics Services Sales Value by Research Areas (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by Research Areas, 2025 & 2032

Figure 25. Product Picture of Clinical Diagnostics

Figure 26. Product Picture of Drug Discovery

Figure 27. Product Picture of Others

Figure 28. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by Application, 2025 & 2032

Figure 30. North America Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 31. North America Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

Figure 32. Europe Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 33. Europe Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

Figure 34. Asia Pacific Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 35. Asia Pacific Spatial Proteomics and Transcriptomics Services Sales Value by Subregion (%), 2025 vs 2032

Figure 36. South America Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 37. South America Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

Figure 38. Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 39. Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value by Country (%), 2025 vs 2032

Figure 40. Key Countries/Regions Spatial Proteomics and Transcriptomics Services Sales Value (%), 2021–2032

Figure 41. United States Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 42. United States Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 43. United States Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 44. Europe Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 45. Europe Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 46. Europe Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 47. China Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 48. China Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 49. China Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 50. Japan Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 51. Japan Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 52. Japan Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 53. South Korea Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 54. South Korea Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 55. South Korea Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 56. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 57. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 58. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 59. India Spatial Proteomics and Transcriptomics Services Sales Value (US$ Million), 2021–2032

Figure 60. India Spatial Proteomics and Transcriptomics Services Sales Value by Type (%), 2025 vs 2032

Figure 61. India Spatial Proteomics and Transcriptomics Services Sales Value by Application (%), 2025 vs 2032

Figure 62. Spatial Proteomics and Transcriptomics Services Value Chain

Figure 63. Spatial Proteomics and Transcriptomics Services Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Spatial Proteomics and Transcriptomics Services in 2026? zhanKai

The global market size of Spatial Proteomics and Transcriptomics Services in 2026 was 210 Million USD.

Which companies rank high in the global Spatial Proteomics and Transcriptomics Services market? shouQi

What is the annual compound growth rate of the global Spatial Proteomics and Transcriptomics Services market size from 2026 to 2032? shouQi

What was the global market size of Spatial Proteomics and Transcriptomics Services in 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Spatial Proteomics and Transcriptomics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Proteomics and Transcriptomics Services market size was US$ 188 million in 2025 and is forecast to reach a readjusted size of US$ 470 million by 2032 with a CAGR of 14.4% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 192
USD 4250.00
(Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Proteomics and Transcriptomics Services market is projected to grow from US$ 188 million in 2025 to US$ 470 million by 2032, at a CAGR of 14.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 210
USD 4900.00
(Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Research Report 2026
The global Spatial Proteomics and Transcriptomics Services market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 470 million by 2032, at a CAGR of 14.4% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 187
USD 2900.00
(Single User License)

Global Spatial Proteomics and Transcriptomics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Proteomics and Transcriptomics Services market size was US$ 188 million in 2025 and is forecast to reach a readjusted size of US$ 470 million by 2032 with a CAGR of 14.4% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 192
USD 4250.00 (Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Proteomics and Transcriptomics Services market is projected to grow from US$ 188 million in 2025 to US$ 470 million by 2032, at a CAGR of 14.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 210
USD 4900.00 (Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Research Report 2026
The global Spatial Proteomics and Transcriptomics Services market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 470 million by 2032, at a CAGR of 14.4% from 2026 to 2032.
Published: 2026-07-17
Pages: 187
USD 2900.00 (Single User License)